Skip to main content
OpenTrials

Clinical trial condition

Primary Biliary Cholangitis

Explore clinical trials studying Primary Biliary Cholangitis. Study availability and eligibility vary by location and protocol.

52 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Primary Biliary Cholangitis trial results

Completed

Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)

NCT06060665

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • The Institute for Liver Health II LLC dba Arizona Clinical Trials; Arizona Liver Health Chandler, Arizona, United States
  • California Liver Research Institute Pasadena, California, United States
  • University of California (UC) Davis Medical Center Sacramento, California, United States
  • California Pacific Medical Center San Francisco, California, United States
View all 45 locations
View Trial Details
Completed

An Open-Label Study Following Oral Dosing of Seladelpar to Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)

NCT04950764

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +11 more
Locations
  • Arizona Liver Health Chandler, Arizona, United States
  • University of California Davis Sacramento, California, United States
  • University of Colorado Anschutz Aurora, Colorado, United States
  • Mercy Medical Center Baltimore, Maryland, United States
View all 20 locations
View Trial Details
Completed

A Study Describing Scratch and Sleep Patterns in Patients With Primary Biliary Cholangitis (Luminaria)

NCT07049887

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Arizona Liver Center Chandler, Arizona, United States
  • University of Miami School of Medicine, Center for Liver Diseases Miami, Florida, United States
  • UT Southwestern Medical Center, Department of Internal Medicine, Digestive and Liver Diseases Dallas, Texas, United States
View Trial Details
Completed

Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

NCT05104853

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Southern California Research Center Coronado, California, United States
  • OM Research Lancaster, California, United States
  • University of California Davis Health Sacramento, California, United States
  • Peak Gastroenterology Associates Colorado Springs, Colorado, United States
View all 19 locations
View Trial Details
Completed

A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis and Without Cirrhosis.

NCT06525311

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +10 more
Locations
  • Arizona Liver Health Chandler, Arizona, United States
  • Southern California Research Center, Inc Coronado, California, United States
  • Indiana University School of Medicine - Indianapolis Indianapolis, Indiana, United States
  • Houston Research Institute Houston, Texas, United States
View Trial Details
Completed

A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness

NCT05014672

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +10 more
Locations
  • UA Thomas D. Boyer Liver Institute Tucson, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • California Liver Research Institute Pasadena, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
View all 128 locations
View Trial Details

Related conditions